Extend your brand profile by curating daily news.

FAQ: Exosome-Based Stem 3 Protocol Hair Restoration by Springs Rejuvenation

Springs Rejuvenation has expanded its proprietary Stem 3 Protocol for non-surgical hair restoration to five US cities: New York City, Los Angeles, Austin, Miami, and Atlanta. The protocol combines peptide therapy, exosome hair treatment, and micro FUE with 0.9mm instrumentation to minimize scalp trauma and enhance recovery.
FAQ: Exosome-Based Stem 3 Protocol Hair Restoration by Springs Rejuvenation

The Stem 3 Protocol is a non-surgical hair restoration treatment developed by Springs Rejuvenation. It combines three components: peptide therapy, exosome hair treatment, and micro follicular unit extraction (micro FUE) using 0.9mm instrumentation.

Exosomes are extracellular vesicles derived from stem cells that carry signaling proteins and growth factors. They communicate with hair follicle cells to prime the scalp before and after micro FUE, extending the active growth phase of the hair cycle and reinforcing follicle density.

The protocol is available at Springs Rejuvenation clinics in New York City, Los Angeles, Austin, Miami, and Atlanta.

The medical director is Dr. Charles Pereyra, MD, who leads the physician-supervised clinics.

The 0.9mm punch diameter is smaller than conventional FUE methods (1.0mm to 1.5mm), which minimizes scalp trauma and supports faster tissue recovery.

Peptide therapy is administered as a preparatory step to optimize cellular conditions in the scalp before the exosome treatment and micro FUE procedure.

Previously, patients sought exosome-based hair restoration in Europe, Mexico, or Southeast Asia due to more permissive regulations. Springs Rejuvenation offers the same advanced protocol domestically, eliminating the need for international travel.

Patients seeking non-surgical hair restoration with regenerative techniques may benefit. Each candidate undergoes an intake assessment before the protocol is initiated.

Yes, in addition to hair restoration, they provide stem cell exosome therapy for joint conditions, operating as integrated regenerative medicine centers.

NewsRamp Editorial Team

NewsRamp Editorial Team

@newsramp

NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.